Author:
Shimomura Akihiko,Yonemori Kan,Yoshida Masayuki,Yoshida Teruhiko,Yasojima Hiroyuki,Masuda Norikazu,Aogi Kenjiro,Takahashi Masato,Naito Yoichi,Shimizu Satoru,Nakamura Rikiya,Hamada Akinobu,Michimae Hirofumi,Hashimoto Jun,Yamamoto Harukaze,Kawachi Asuka,Shimizu Chikako,Fujiwara Yasuhiro,Tamura Kenji
Reference39 articles.
1. Cancer Information Service Center NCC. Cancer Information Service 2015 [Available from: http://ganjoho.jp/public/index.html.
2. The Japanese Breast Cancer Society clinical practice guideline for surgical treatment of breast cancer, 2015 edition;Jinno;Breast Cancer,2016
3. Eribulin monotherapy versus treatment of physician’s choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study;Cortes;Lancet,2011
4. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry;Bauer;Cancer,2007
5. Rakha EA, Tan DS, Foulkes WD, Ellis IO, Tutt A, Nielsen TO, et al. Are triple-negative tumours and basal-like breast cancer synonymous? Breast Cancer Res. 2007;9(6):404; author reply 5.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献